Latest revenue
$19.1M
as of 2026-03-31
Latest net income
$-10.6M
as of 2026-03-31
Net margin
-55.7%
as of 2026-03-31
ActaClear Score
Computed from 5 years of SEC fundamentals + latest market data, ranked within Surgical & Medical Instruments & Apparatus (138 peers). 10 = best in industry, 5 = median, 0 = worst. Refreshed Jun 6, 2026.
Community sentiment
Where do you think AVHHL is heading?
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $26.0M
- Enterprise value
- $63.8M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $1.35
- 52-wk low
- $0.56
- Beta
- —
- Shares out
- 30.8M
5-year trend
What this company does
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of AVITA Medical, Inc.’s (“AVITA Medical”, the “Company”), “we”, “our”, or “us”) financial condition and results of operations should be read in conjunction with our unaudited Consolidated Financial Statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q as well as the “Note Regarding Forward-Looking Statements” on page 3. Overview We are a leading therapeutic acute wound care company delivering transformative solutions. Our solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs,…
AI summary unavailable — showing raw filing excerpt
Generated from AVHHL's filing dated 2026-05-14
Key risks
Item 1A. RISK FACTORS In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed under Part I, Item 1A, “Risk Factors,” in the 2025 Annual Report and as updated from time to time in the Company’s subsequent Quarterly Reports on Form 10-Q. These factors could materially adversely affect our business, financial condition, liquidity, results of operations and capital position, and could cause our actual results to differ materially from our historical results or the results contemplated by the forward-looking statements contained in this Quarterly Report on Form 10-Q. There have been no material changes to the risk…
AI summary unavailable — showing raw filing excerpt
Generated from AVHHL's filing dated 2026-05-14
Profitability
Gross margin
82.1%
4.3%Operating margin
-59.4%
32.6%Net margin
-67.8%
29.5%Return on equity
-1080.0%
756.6%Return on assets
-86.2%
11.0%Leverage
Debt / equity
11.53×
1745.8%Long-term debt / equity
0.00×
100.0%Debt / assets
92.0%
139.3%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $19.1M | +4.0% | $-10.6M | +23.4% | -55.7% |
Q4 2025 2025-12-31 | $18.2M | -2.2% | $-11.6M | -0.3% | -64.0% |
Q3 2025 2025-09-30 | $16.9M | -12.9% | $-13.2M | +18.6% | -78.0% |
Q2 2025 2025-06-30 | $18.2M | +20.0% | $-9.9M | +35.6% | -54.4% |
Q1 2025 2025-03-31 | $18.3M | +65.0% | $-13.9M | +25.7% | -75.6% |
Q4 2024 2024-12-31 | $18.6M | — | $-11.6M | — | -62.4% |
Q3 2024 2024-09-30 | $19.4M | +42.1% | $-16.2M | -86.0% | -83.6% |
Q2 2024 2024-06-30 | $15.2M | +29.2% | $-15.4M | -48.2% | -101.4% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Surgical & Medical Instruments & Apparatus · SIC 3841
Your notes
Keep private notes on AVHHL — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$151.7K
Insider selling
$0
Net activity
+$151.7K
Distinct insiders
2
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns AVHHL
No institutional holdings on file for AVHHL yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once AVHHL's latest filing finishes processing.
Sign in to vote. Votes use 7-day half-life decay.
Sign in to tap. 7-day half-life decay.